IL-8 receptor antagonists
US5929250A · kind A · utility
37Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 1998 |
| Grant date | Jul 27, 1999 |
| Priority date | — |
| Expiry date | Jul 23, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D261/20
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to novel compounds of Formula (II), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.